| No headlines available for ARVAX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
110.48M |
| Category: |
Mid-Cap Value |
| Total Expense Ratio: |
1.18% |
|
| PERFORMANCE & RISK | 31-Dec-07
| YTD Return: |
0.56% |
| 5y Avg Return: |
17.79% |
| Rank in Category (ytd): |
202 |
| % Rank in Category (ytd): |
49.88% |
| Beta (3y): |
1.06 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of assets in securities issued by mid cap companies. It primarily invests in domestic equity securities.The fund considers a mid cap company to be one that has a market capitalization at the time of purchase between $1.2 billion and $19.5 billion. It seeks to invest in companies trading at a discount to intrinsic value with a margin of safety, utilizing a discounted cash flow methodology. |
|
| Fund Profile |
|
Help
0.02 (0.19%) 
Summary
Add ARVAX to Portfolio 
Download Data
